Versant Capital Management’s Lifecore Biomedical LFCR Stock Holding History

Versant Capital Management’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-284	Closed	-$3K	–	1528
2021 Q1	$3K	Hold	284	–	–	﹤0.01%	1162
2020 Q4	$3K	Sell	284 -18	-6%	-$186	﹤0.01%	1054
2020 Q3	$2K	Hold	302	–	–	﹤0.01%	1077
2020 Q2	$2K	Hold	302	–	–	﹤0.01%	1073
2020 Q1	$2K	Hold	302	–	–	﹤0.01%	1021
2019 Q4	$3K	Hold	302	–	–	﹤0.01%	1068
2019 Q3	$3K	Hold	302	–	–	﹤0.01%	1092
2019 Q2	$2K	Hold	302	–	–	﹤0.01%	1189
2019 Q1	$3K	Hold	302	–	–	﹤0.01%	1256
2018 Q4	$3K	Hold	302	–	–	﹤0.01%	1167
2018 Q3	$4K	Hold	302	–	–	﹤0.01%	1150
2018 Q2	$4K	Hold	302	–	–	﹤0.01%	1147
2018 Q1	$3K	Sell	302 -281	-48%	-$3.69K	﹤0.01%	1200
2017 Q4	$7K	Hold	583	–	–	﹤0.01%	1033
2017 Q3	$7K	Hold	583	–	–	﹤0.01%	966
2017 Q2	$8K	Hold	583	–	–	﹤0.01%	928
2017 Q1	$6K	Sell	583 -6	-1%	-$76	﹤0.01%	993
2016 Q4	$8K	Sell	589 -47	-7%	-$651	﹤0.01%	897
2016 Q3	$8K	Hold	636	–	–	﹤0.01%	878
2016 Q2	$6K	Hold	636	–	–	﹤0.01%	925
2016 Q1	$6K	Sell	636 -67	-10%	-$736	﹤0.01%	912
2015 Q4	$8K	Buy	+703	New	+$8.63K	0.01%	800

Other funds holding LFCR

Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return

LPAM

Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CSC

Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ICOM

Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Versant Capital Management's LFCR Position: Q2 2021 in Review

Versant Capital Management sold out of Lifecore Biomedical (LFCR) in Q2 2021, closing a stake of 284 shares — an estimated $3K sold.

Versant Capital Management first reported a position in LFCR in Q4 2015 and held it in 22 quarters. The position peaked at $8K in Q2 2017. 95 funds tracked by Wall St. Rank hold LFCR as of Q2 2021.

Versant Capital Management reported no remaining Lifecore Biomedical position as of Q2 2021 after selling out during the quarter.
Versant Capital Management sold 284 Lifecore Biomedical shares in Q2 2021, an estimated $3K.
Versant Capital Management first reported a position in Lifecore Biomedical in Q4 2015 and held it in 22 quarters.
Versant Capital Management's Lifecore Biomedical position peaked at $8K in Q2 2017.
95 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2021.

Based on Versant Capital Management's 13F filing for Q2 2021, filed 22 Jul 2021.